We’re excited to announce our partnership with Pupil Labs GmbH. By combining Cognixion’s noninvasive Brain-Computer Interface (BCI), Artificial Intelligence (AI), and Augmented Reality (AR) technologies with Pupil Labs’ advanced eye-tracking solutions, we’re creating a powerful new interface that measures both visual attention and neural signals. Their eye-tracking software will integrate with the Axon-R SDK, enabling seamless, cross-platform data collection and analysis.
High-precision eye tracking and advanced BCI electroencephalogram (EEG) capabilities will give clinical researchers powerful new tools for neuroscience, human-computer interaction, and assistive technology research. The combined technology will provide a higher level of data confidence, and a platform that can adapt to the unique needs of patients where disease progression may impact eye gaze ability, such as amyotrophic lateral sclerosis (ALS). The partnership addresses a significant need in the research community for unified tools that can simultaneously track visual attention and neural activity with research-grade precision.
“By combining Cognixion’s neural interface expertise with Pupil Labs’ industry-leading eye tracking technology, we’re filling a critical role in sensor architecture that isn’t available with any current brain-computer interface technologies,” said Andreas Forsland, CEO of Cognixion.
“This partnership enables a new generation of studies that can correlate visual attention with neural activity in real-time, potentially transforming our understanding of human cognition and interaction.”
The integrated solution will allow researchers to:
● Rapidly prototype and deploy studies that simultaneously measure eye movements and brain activity
● Leverage research-grade sensors for both modalities without complex technical integration
● Access synchronized data streams through a unified developer interface
● Develop applications that respond to both visual attention and neural signals
“We’ve seen growing demand for combined eye-tracking and EEG solutions from our research partners,” said Moritz Kassner, CEO of Pupil Labs. “This collaboration with Cognixion addresses that need with a seamless integration that maintains the fidelity researchers expect from both technologies while dramatically reducing technical barriers.”
The integration is expected to be particularly valuable for clinical researchers studying attention, cognitive load, human-computer interaction, and assistive technologies for individuals with motor impairments.
Technical teams from both companies have begun the integration process, with initial releases expected within six months. The companies will also collaborate on joint marketing efforts and educational resources for the research community.
